Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation
NCT02426684
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
17
Enrollment
OTHER
Sponsor class
Conditions
Renal Disease
Interventions
DRUG:
IdeS® (Imlifidase)
Sponsor
Cedars-Sinai Medical Center
Collaborators
[object Object]